Synthesis and breakdown of fibrillar collagens: concomitant phenomena in ovarian cancer

Abstract

Summary The synthesis and degradation of type I and type IlIl interstitial collagens releases several antigenic metabolites, whose measurement allows the metabolism of connective tissue to be evaluated under a variety of different conditions. In this study we investigated the influence of benign and malignant ovarian neoplasms on the metabolism of these collagens. The study population comprised patients with benign (n = 53), borderline (n = 6) or malignant (n = 36) ovarian neoplasms. We quantified the serum, cyst fluid and peritoneal/ascitic fluid concentrations of the amino-terminal propeptide of type (PINP) and IlIl (PIIINP) procollagens, indicators of the synthesis of type and IlIl collagen, respectively and the cross-linked carboxy-terminal telopeptide of type I collagen (ICTP), ani indicator of type I collagen degradation.Macrophage colony-stimulating factor 1 (CSF-1) concentration was also assayed as its serum level is increased in ovarian cancer and CSF-1 may be involved in the regulation of collagen metabolism. The concentration of each antigen was significantly higher in patients with malignant tumour than with benign neoplasm in each comparison, except for ICTP in peritoneal fluid and for CSF-1 in cyst fluid. The high ascitic fluid concentration of PINP, PIIINP or CSF-1 correlated with malignancy, and the low cyst fluid concentration of any of the four markers was indicative of benign tumour. Levels of CSF-1 did not correlate with the levels of any of the markers of collagen turnover. The concentration of PINP in ascites was about 50 times higher and in cyst fluid about eight times higher than that in the serum from patients with malignant tumour, whereas the respective ratios for ICTP were only 2.5 and 1.3. In such patients, the ratio of ascitic fluid to serum concentration was also about 80-fold higher for PIIINP and about 20-fold higher for PINP than for ICTP. The different distributions of PIIINP, PINP and ICTP suggests dominance of synthetic processes or retarted elimination of PIIINP and PINP in ovarian cancer. In advanced malignancies, the accumulation of PINP and PIIINP in abdominal space, possibly due to increased synthesis and/or failed resorption, may promote ascites formation. This study shows that both accelerated synthesis and breakdown of fibrillar collagens are characteristic of ovarian malignancy, and suggests that measurements of cyst fluid or ascitic fluid concentrations of collagen metabolites or CSF-1 could be used in the differential diagnosis of benign and malignant ovarian neoplasms.Keywords: matrix reaction; type collagen; type IlIl collagen; macrophage colony-stimulating factor 1; tumour-associated marker; ascites formationThe growth and dissemination of malignant neoplasms are accompanied by complex biochemical events that alter collagen metabolism. During tumour growth and dissemination the increased synthesis of proteolytic enzymes with the consequent disruption of collagen architecture is a prerequisite for neoplastic cell invasion and dissemination (Liotta, 1986; van den ...

Integrin Regulation of β-Catenin Signaling in Ovarian Carcinoma

“…Modulation of cell-cell and cell-matrix adhesion are key events in ovarian cancer metastasis, as intraperitoneal adhesion of malignant cells and multicellular aggregates combined with localized integrin-mediated invasion of the collagen-rich submesothelial matrix are necessary to anchor secondary lesions (5,40). Intraperitoneal ovarian cancer metastasis is mediated by adhesion via integrins ␣2␤1 and ␣3␤1 to peritoneal mesothelial cells displaying surface expression of collagen and the exposed interstitial (types I and III) collagen-rich submesothelial matrix, and antibodies directed against these integrins block collagen binding (41)(42)(43)(44)(45)(46)(47). Integrin engagement by a multivalent matrix ligand results in receptor aggregation, functionally coupling the extracellular environment to specific signal transduction pathways that modulate distinct cellular responses, including gene transcription, cell migration, and survival (48).…”

Ets1 Is an Effector of the Transforming Growth Factor β (TGF-β) Signaling Pathway and an Antagonist of the Profibrotic Effects of TGF-β

“…High levels of TGF-␤ observed in tumor stroma, together with elevated expression of Ets1 in a subset of stromal cells may result in a microenvironment characterized by both enhanced synthesis and enhanced breakdown of fibrillar collagens. Such a microenvironment has been linked, for example, to malignant ovarian neoplasms (66). The mechanisms of Ets1 transcriptional activation/repression of the TGF-␤ pathway merits further investigation.…”

Inhibition of Ovarian Tumor Growth by Targeting the HU177 Cryptic Collagen Epitope

“…31,32 In this regard, we examined biopsy specimens of human ovarian tumors and benign granulomas for expression of the HU177 cryptic collagen epitope. Serial sections from frozen tissues were stained by hematoxylin and eosin or with anti-HU177 antibody.…”